A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides

Current Biology

Volumn 5, Issue 4, 1995, Pages 404-412

  van der Geer, Peter ^a   Wiley, Sandra ^a   Ka Man Lai, Venus ^a   Olivier, Jean Paul ^a   Gish, Gerald D ^a   Stephens, Robert ^b   Kaplan, David ^b   Shoelson, Steven ^c   Pawson, Tony ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

52 KDA SHC PROTEIN; 52-KDA SHC PROTEIN; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; NERVE GROWTH FACTOR RECEPTOR; PHOSPHOPEPTIDE; PHOSPHOTYROSINE; PROTEIN; TYROSINE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL LINE; CELL STRAIN 3T3; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; ONCOGENE SRC; PHOSPHORYLATION; SEQUENCE HOMOLOGY;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMAL; CELL LINE, TRANSFORMED; CONSERVED SEQUENCE; GENES, SRC; GLUTATHIONE TRANSFERASE; HUMAN; MICE; MOLECULAR SEQUENCE DATA; PHOSPHOPEPTIDES; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SUPPORT, NON-U.S. GOV'T; TYROSINE;

EID: 0029278769     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(95)00081-9     Document Type: Article

References (52)

1. Receptor protein-tyrosine kinases and their signal transduction pathways
2. Signal transduction by receptors with tyrosine kinase activity
3. Allosteric regulation of the epidermal growth factor receptor kinase
4. Tyrosine kinases and their interactions with signalling proteins
5. SH2 and SH3 domains
6. gag-crk, to a broad range of phosphotyrosine-containing proteins
7. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins
8. gag-fps
9. The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity
10. A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine
11. SH2 domain specificity and activity modified by a single residue
12. SH2 domains recognize specific phosphopeptide sequences
13. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav
14. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides
15. lck
16. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
17. Multiple cytokines induce the tyrosine phosphorylation of Shc and its association with Grb2 in hemopoietic cells
18. Identification of SHC as a substrate of the insulin receptor kinase distinct from the GAP-associated 62 kDa tyrosine phosphoprotein
19. Shc products are substrates of erbB-2 kinase
20. Epidermal growth factor stimulates the tyrosine phosphorylation of SHC in the mouse
21. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins
22. shc in T lymphocytes
23. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in the activation of the Ras pathway by tyrosine kinases
24. Bcr–Abl oncoproteins bind directly to activators of the Ras signalling pathway
25. Shc proteins are phosphorylated and regulated by the v-Src and v-Fps proteintyrosine kinases
26. Formation of Shc–Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins
27. C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains
28. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling
29. A Drosophila SH2–SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of Ras guanine nucleotide exchange, Sos
30. ras through the formation of a complex of the receptor, Grb2 adaptor protein, and Sos nucleotide exchange factor
31. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation
32. Grb2 mediates EGF-dependent activation of guanine nucleotide exchange on Ras
33. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling
34. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1
35. Phosphorylation of the SHC proteins on tyrosine correlates with the transformation of fibroblasts and erythroblasts by the v-sea tyrosine kinase
36. Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor
37. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc
38. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn–Pro–Thr–Tyr) motif in middle tumor antigen
39. Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera
40. Identification of Trk binding sites for SHC and phosphatidylinositol 3′-kinase and formation of a multimeric signaling complex
41. Tyrosine 785 is the major determinant of Trk–substrate interaction
42. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses
43. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma
44. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors
45. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes
46. Direct interaction between Shc and the platelet-derived growth factor beta-receptor
47. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases
48. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins
49. A region distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors
50. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing
51. gag-fps
52. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine